Advanced BioMedical Technologies, Inc. (ABMT)

0.0006 0.0000 (0.00%) 收市：12:15PM EDT

Advanced BioMedical Technologies, Inc.

200 Park Avenue
Suite 1700
New York, NY 10166
United States
718 766 7898
https://abtlafleur.com

版塊: Healthcare
行業: Medical Devices
全職員工: 17

高階主管

名稱	頭銜	支付	行使價	出生年份
Ms. Hui Wang	CEO, Controller & Director	34.6k	無	1970
Mr. Chi Ming Yu	President, Treasurer, Compliance Officer & Director	無	無	1974
Mr. Kai Gui	Secretary, CFO, COO & Director	無	無	1970
Prof. Puyi Sheng M.D., Ph.D.	Chief Medical Officer	無	無	1968
Prof. Shangli Liu M.D., Ph.D.	Chairman of Scientific Board & Chief Medical Advisor of Greater China	無	無	無
Dr. John Thomas Lynch Jr.	Chief Officer of Dental Technologies	無	無	無

截止 2020年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.

公司管治

截至 無 止，Advanced BioMedical Technologies, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。